Monocyte to high-density lipoprotein ratio as a predictive biomarker for in-hospital mortality following surgery for type A aortic dissection: Reality or myth?

Despite the advancement in surgical and perfusion techniques, surgical management of TAAD remains associated with relatively high risk of mortality and morbidity. Using prognostic biomarkers such as MHR can provide a means of reducing in-hospital mortality by identifying those at risk. Yet, further research into this area is encouraged.